Leto Medical, a privately held early-stage medical device company, has received US Patent and Trademark Office grant of two patents 7,765,006 and 7,765,007 for its Continent Ostomy System (COS) technology, a system of products that will restore continence control to individuals with colostomies.
Leto’s Continent Ostomy System is a family of products currently under development that will restore continence control to individuals who have been rendered incontinent as a result of colostomy surgery.
The System has an electrical stimulation device that, when in use, will actively control the terminal segment of the individual’s colon.
Leto said that the device, along with the System’s single-use disposables, will allow individuals with colostomies to manage their fecal output without the use of ostomy bags.
Jim Schneider, president of Leto Medical, said: “These patents are the foundation upon which Leto Medical is building its Continent Ostomy System intellectual property estate. Their issuance is an important milestone for the company.
“They are the first in what we believe will be a large family of patents that will protect our proprietary ostomy management technology, a technology that will improve the Quality of Life of tens of thousands of individuals with colostomies by freeing them from 24/7 dependence on ostomy bags.”